Global Radiodermatitis Treatment Market 2019-2023

放射線皮膚炎治療の世界市場2019-2023

◆タイトル:Global Radiodermatitis Treatment Market 2019-2023
◆商品コード:IRTNTR31251
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2019年5月16日
◆ページ数:133
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル、アジア、北米、ヨーロッパ(EMEA)
◆産業分野:Health Care
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥267,500見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥321,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥428,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、放射線皮膚炎治療の世界市場について調査・分析し、市場概要、市場環境、放射線皮膚炎治療市場規模、製品別(局所的、ドレッシング材、口内)分析、市場動向、競争環境、主要地域別市場規模(北米、ヨーロッパ、アジアなど)、関連企業情報などを含め、以下の構成でお届け致します。
・エグゼクティブサマリー
・調査範囲・調査手法
・放射線皮膚炎治療の世界市場概要
・放射線皮膚炎治療の世界市場環境
・放射線皮膚炎治療の世界市場動向
・放射線皮膚炎治療の世界市場規模
・放射線皮膚炎治療の世界市場:業界構造分析
・放射線皮膚炎治療の世界市場:製品別(局所的、ドレッシング材、口内)
・放射線皮膚炎治療の世界市場:地域別市場規模・分析
・放射線皮膚炎治療の北米市場規模・予測
・放射線皮膚炎治療のヨーロッパ・中東・アフリカ市場規模・予測
・放射線皮膚炎治療のアジア太平洋市場規模・予測
・放射線皮膚炎治療の主要国分析
・放射線皮膚炎治療の世界市場:意思決定フレームワーク
・放射線皮膚炎治療の世界市場:成長要因、課題
・放射線皮膚炎治療の世界市場:競争環境
・放射線皮膚炎治療の世界市場:関連企業情報(ベンダー分析)

About this market

Several rising initiatives by research institutes are impacting the radiodermatitis treatment market growth during the forecast period. Existing vendors are further striving to evaluate the therapeutic efficacy of a wide range of radiodermatitis treatment products for leveraging their product portfolio. Researchers from different universities are using low-intensity laser therapy in breast cancer patients for preventing and controlling the symptoms of this health condition. As a result, initiatives by several research institutes will lead to the radiodermatitis treatment market growth during the forecast period. Technavio’s analysts have predicted that the radiodermatitis treatment market will register a CAGR of over 4% by 2023.

Market Overview

The rising number of public and private healthcare organizations

Promoting awareness about radiodermatitis diagnosis and treatment and increasing the adoption of radiodermatitis products. This will drive the growth of the market during the forecast period.

Advent of novel radiation equipment with fewer side-effects

The global radiodermatitis treatment market is currently witnessing the advent of novel radiation equipment with fewer side-effects, leading to a decrease in demand for radiodermatitis drugs, thereby hindering the market growth.

For the detailed list of factors that will drive and challenge the growth of the radiodermatitis treatment market during 2019-2023, view our report.

Competitive Landscape

The market appears to be moderately fragmented with the presence of several market players. Several vendors are focusing on the concept of moisture therapy, which involves moisturizing the wound area to promote natural cell repair while giving the injured cells sufficient time to recover. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.

【資料の目次】

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

2.1 Preface

2.2 Preface

2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

Market ecosystem

Market characteristics

Market segmentation analysis

PART 04: MARKET SIZING

Market definition

Market sizing 2018

Market size and forecast 2018-2023

PART 05: DISEASE OVERVIEW

PART 06: FIVE FORCES ANALYSIS

Bargaining power of buyers

Bargaining power of suppliers

Threat of new entrants

Threat of substitutes

Threat of rivalry

Market condition

PART 07: PIPELINE

PART 08: MARKET SEGMENTATION BY PRODUCT

Market segmentation by product

Comparison by product

Topical – Market size and forecast 2018-2023

Dressings – Market size and forecast 2018-2023

Oral – Market size and forecast 2018-2023

Market opportunity by product

PART 09: CUSTOMER LANDSCAPE

PART 10: MARKET SEGMENTATION BY DISTRIBUTION CHANNEL

PART 11: GEOGRAPHIC LANDSCAPE

Geographic segmentation

Geographic comparison

Asia – Market size and forecast 2018-2023

North America – Market size and forecast 2018-2023

Europe – Market size and forecast 2018-2023

ROW – Market size and forecast 2018-2023

Key leading countries

Market opportunity

PART 12: DECISION FRAMEWORK

PART 13: DRIVERS AND CHALLENGES

Market drivers

Market challenges

PART 14: MARKET TRENDS

PART 15: VENDOR LANDSCAPE

Overview

Landscape disruption

Competitive scenario

PART 16: VENDOR ANALYSIS

Vendors covered

Vendor classification

Market positioning of vendors

3M

Acelity LP Inc.

ConvaTec Group Plc

Mölnlycke Health Care AB

Smith & Nephew Plc

PART 17: APPENDIX

Research methodology

List of abbreviations

Definition of market positioning of vendors

PART 18: EXPLORE TECHNAVIO

Exhibit 01: Global pharmaceuticals market

Exhibit 02: Segments of global pharmaceuticals market

Exhibit 03: Market characteristics

Exhibit 04: Market segments

Exhibit 05: Factors driving global radiodermatitis treatment market 2019-2023

Exhibit 06: Market definition – Inclusions and exclusions checklist

Exhibit 07: Market size 2018

Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)

Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)

Exhibit 10: Types of radiodermatitis

Exhibit 11: Epidemiology statistics of cancer in the US

Exhibit 12: Five forces analysis 2018

Exhibit 13: Five forces analysis 2023

Exhibit 14: Bargaining power of buyers

Exhibit 15: Bargaining power of suppliers

Exhibit 16: Threat of new entrants

Exhibit 17: Threat of substitutes

Exhibit 18: Threat of rivalry

Exhibit 19: Market condition – Five forces 2018

Exhibit 20: Pipeline landscape

Exhibit 21: Some of the drugs investigated for radiodermatitis

Exhibit 22: Product – Market share 2018-2023 (%)

Exhibit 23: Comparison by product

Exhibit 24: Topical – Market size and forecast 2018-2023 ($ millions)

Exhibit 25: Topical – Year-over-year growth 2019-2023 (%)

Exhibit 26: Dressings – Market size and forecast 2018-2023 ($ millions)

Exhibit 27: Dressings – Year-over-year growth 2019-2023 (%)

Exhibit 28: Oral – Market size and forecast 2018-2023 ($ millions)

Exhibit 29: Oral – Year-over-year growth 2019-2023 (%)

Exhibit 30: Market opportunity by product

Exhibit 31: Customer landscape

Exhibit 32: Market share by distribution channel, 2018

Exhibit 33: Market share by geography 2018-2023 (%)

Exhibit 34: Geographic comparison

Exhibit 35: Asia – Market size and forecast 2018-2023 ($ millions)

Exhibit 36: Incidence rate of lung cancer

Exhibit 37: Asia – Year-over-year growth 2019-2023 (%)

Exhibit 38: Top 3 countries in Asia

Exhibit 39: North America – Market size and forecast 2018-2023 ($ millions)

Exhibit 40: Key industry trends in North America

Exhibit 41: North America – Year-over-year growth 2019-2023 (%)

Exhibit 42: Top 3 countries in North America

Exhibit 43: Europe – Market size and forecast 2018-2023 ($ millions)

Exhibit 44: Incidence rate of cancer in Germany, 2012

Exhibit 45: Projected incidence rate of cancer in Germany, 2030

Exhibit 46: Europe – Year-over-year growth 2019-2023 (%)

Exhibit 47: Top 3 countries in Europe

Exhibit 48: ROW – Market size and forecast 2018-2023 ($ millions)

Exhibit 49: Facts about cancer in Australia

Exhibit 50: ROW – Year-over-year growth 2019-2023 (%)

Exhibit 51: Top 3 countries in ROW

Exhibit 52: Key leading countries

Exhibit 53: Market opportunity

Exhibit 54: Cancer prevalence in US in 2015

Exhibit 55: Cancer prevalence in England in 2016

Exhibit 56: Types of external beam radiation therapy

Exhibit 57: Impact of drivers and challenges

Exhibit 58: CDC statistics for obesity and diabetes

Exhibit 59: Vendor landscape

Exhibit 60: Landscape disruption

Exhibit 61: Vendors covered

Exhibit 62: Vendor classification

Exhibit 63: Market positioning of vendors

Exhibit 64: M – Vendor overview

Exhibit 65: M – Business segments

Exhibit 66: M – Organizational developments

Exhibit 67: M – Geographic focus

Exhibit 68: M – Segment focus

Exhibit 69: M – Key offerings

Exhibit 70: M – Key customers

Exhibit 71: Acelity LP Inc. – Vendor overview

Exhibit 72: Acelity LP Inc. – Organizational developments

Exhibit 73: Acelity LP Inc. – Key offerings

Exhibit 74: Acelity LP Inc. – Key customers

Exhibit 75: ConvaTec Group Plc – Vendor overview

Exhibit 76: ConvaTec Group Plc – Product segments

Exhibit 77: ConvaTec Group Plc – Organizational developments

Exhibit 78: ConvaTec Group Plc – Geographic focus

Exhibit 79: ConvaTec Group Plc – Segment focus

Exhibit 80: ConvaTec Group Plc – Key offerings

Exhibit 81: ConvaTec Group Plc – Key customers

Exhibit 82: Mölnlycke Health Care AB – Vendor overview

Exhibit 83: Mölnlycke Health Care AB – Product segments

Exhibit 84: Mölnlycke Health Care AB – Organizational developments

Exhibit 85: Mölnlycke Health Care AB – Geographic focus

Exhibit 86: Mölnlycke Health Care AB – Segment focus

Exhibit 87: Mölnlycke Health Care AB – Key offerings

Exhibit 88: Mölnlycke Health Care AB – Key customers

Exhibit 89: Smith & Nephew Plc – Vendor overview

Exhibit 90: Smith & Nephew Plc – Business segments

Exhibit 91: Smith & Nephew Plc – Organizational developments

Exhibit 92: Smith & Nephew Plc – Geographic focus

Exhibit 93: Smith & Nephew Plc – Segment focus

Exhibit 94: Smith & Nephew Plc – Key offerings

Exhibit 95: Smith & Nephew Plc – Key customers

Exhibit 96: Validation techniques employed for market sizing

Exhibit 97: Definition of market positioning of vendors



【掲載企業】

3M、Acelity LP Inc.、ConvaTec Group Plc、Mölnlycke Health Care AB、Smith & Nephew Plc.

★調査レポート[放射線皮膚炎治療の世界市場2019-2023] (Global Radiodermatitis Treatment Market 2019-2023 / IRTNTR31251)販売に関する免責事項
[放射線皮膚炎治療の世界市場2019-2023] (Global Radiodermatitis Treatment Market 2019-2023 / IRTNTR31251)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆